期刊文献+

近距离放射疗法与前列腺根治切除治疗局限性前列腺癌的疗效比较——meta分析 被引量:4

Comparison of the therapeutic effect of localized prostate carcinoma treated with radical prostatectomy and brachytherapy
下载PDF
导出
摘要 目的比较前列腺粒子植入近距离放射疗法与根治性前列腺切除术治疗局限性前列腺癌的疗效。方法收集国内外1979年1月至2007年7月已公开发表的有关局限性前列腺癌行根治性前列腺切除术和粒子植入近距离放射治疗疗效比较的临床对照试验文献,对符合要求的研究进行同质性检验,采用四格表数据的Meta分析方法(Peto法)计算比值比(OR)和95%可信区间(CI)。结果符合要求入选的研究文献共有4项,共2305例病例,其中根治性前列腺切除1244例,前列腺粒子植入1061例;两种治疗方法术后5年无瘤存活率合并比值比(OR)是[OR0.68,95%CI(0.44,1.05)],差异无统计学意义。结论根据现有研究资料可知两种治疗方式对于局限性前列腺癌术后5年生存率没有明显差别,两种方法均可作为局限性前列腺癌有效和可靠的治疗手段。 Objective To compare the therapeutic effect of treating localized prostate carcinoma by radical prostatectomy and brachytherapy. Methods Experiment results of brachytherapy and radical prostatectomy to treat localized prostate carcinoma from January 1979 to July 2007 were collected. Meta analysis was used for homogeneity test in studies meeting the criteria. The fourfold Meta analysis (Peto) was used to calculate the odds ratio (OR) and 95% confidence interval (IC). Results Four trials were chosen in the research, in which 1 244 cases were treated using radical prostatectomy and 1 061 using brachytherapy. There was no significant difference 5 years after these two therapy methods. The OR was 0.68, 95% CI (0.44, 1. 05). Conclusion According to current research results, there is no significant difference between radical prostatectomy and brachytherapy in 5-year recurrence-free survival in treating localized prostate carcinoma. These two therapies are effective and safe.
出处 《现代泌尿外科杂志》 CAS 2008年第4期288-290,共3页 Journal of Modern Urology
关键词 前列腺癌 近距离放射治疗 前列腺根治切除术 META分析 prostate carcinoma brachytherapy radical prostatectomy meta analysis
  • 相关文献

参考文献8

  • 1Ramos CG, Carvalhal GF, Smith DS, et al. Retrospective comparison of radical retropubic prostatectomy and 125iodine brachytherapy for localized prostate cancer [J]. J Urol, 1999, 161(4) :1212-1215.
  • 2Fletcher SG, Mills SE, Smolkin ME, et al. Case-Matched comparison of contemporary radiation therapy to surgery in patients with locally advanced prostate cancer[J]. Int J Radiat Oncol Biol Phys, 2006, 66(4):1092-1099.
  • 3Ciezki JP, Klein EA, Angermeier K, et al. A retrospective comparison of androgen deprivation (AD) vs. no AD among low-risk and intermediate-risk prostate cancer patients treated with brachytherapy, external beam radiotherapy, or radical prostatectomy [J]. Int J Radiat Oncol Biol Phys, 2004, 60(5) : 1347-1350.
  • 4Potters L, Klein EA, Kattan MW, et al. Monotherapy for stage T1-T2 prostate cancer: radical prostatcctomy, external beam radiotherapy, or permanent seed implantation [J]. Radiother Oncol, 2004, 71(1) :29-33.
  • 5Hsu IC, Pickett B, Shinohara K, et al. Normal tissue dosimetric comparison between HDR prostate implant boost and conformal external beam radiotherapy boost: potential for dose escalation [J]. Int J Radiat Oncol Biol Phys, 2000, 46(4) :851-858.
  • 6Garzotto M, Fair WR. Historical perspective on prostate brachytherapy [J]. J Endouroh 2000, 14(4):315-818.
  • 7李汉忠.前列腺癌近距离治疗的研究进展[J].继续医学教育,2006,20(11):23-27. 被引量:2
  • 8侯毅,刘立民,那万里,张春福.^(125)I粒子植入在前列腺癌中的应用[J].中国老年学杂志,2005,25(12):1542-1543. 被引量:2

二级参考文献33

  • 1李汉忠,严维刚.前列腺癌近距离治疗的研究进展[J].中华外科杂志,2005,43(2):129-131. 被引量:11
  • 2Garzotto M, William R. Fair: historical perspective on prostate brachytherapy [J]. Endourology ,2000 ; 14(4) :315.
  • 3Hilaris RS. Brachytherapy in cancer of the prostate : a historical perspective[J]. Semin Surg Oncel,1997 ;13:399-405.
  • 4Wirth MP, Froehner M. Value of endocrine therapy for early and locally advanced prostate cancer[J]. Drugs Aging,2003 ;20 : 115-24.
  • 5Stone NN, Stock RG. Prostate brachytherapy : treatment strategies [J]. J Urol, 1999 ; 162:421-6.
  • 6Zelefsky MJ,Whitmore WF Jr.Long-term results of retropubic permanent 125Iodine implantation of the prostate for clinically localized prostatic cancer[J].J Urol,1997,158:23-29.
  • 7Ellis WJ.Prostate brachytherapy[J].Cancer Met Rev,2002,21:125-129.
  • 8Nag S,Beyer D,Friedland J,et al.American Brachytherapy Society recommendations for transperineal permanent brachytherapy of prostate cancer[J].Int J Radiat Oncol Bios Phys,1999,44:789-799.
  • 9Nag S.Brachytherapy for prostate cancer:Summary of American Brachytherapy Society recommendations[J].Semin Urol Oncol,2000,18:133-136.
  • 10Merrick GS,Wallner KE,Butler WM.Permanent interstitial brachytherapy for the management of carcinoma of the prostate gland[J].J Urol,2003,169:1643-1652.

共引文献2

同被引文献32

  • 1黄毅,马潞林,王俊杰,冉维强.^(125)I放射粒子植入治疗激素难治性前列腺癌[J].中华泌尿外科杂志,2004,25(10):701-703. 被引量:18
  • 2李勤,伍钢.调强适形照射技术对前列腺癌放射治疗剂量学的意义[J].放射学实践,2005,20(1):73-76. 被引量:3
  • 3王俊杰,黄毅,冉维强,朱丽红,白静,田素青,李金娜.^(125)I粒子近距离治疗前列腺癌临床应用[J].中华放射医学与防护杂志,2004,24(6):509-512. 被引量:38
  • 4卓水清,陈林,张福君,赵明,张亮,刘健,李奎,吴沛宏,郑庆生,王琰.^(125)I放射性粒子植入术后患者周围辐射剂量的监测[J].癌症,2007,26(6):666-668. 被引量:67
  • 5Kwok Y,Dibiase SJ,Amin PP,et al.Risk group stratification in patients undergoing permanent 125I prostate brachytherapy as monothreapy.Int J Radiat Oncol Biol Phys,2002,53:588-594.
  • 6Gregory SM,Wayne MB,Robert WG,et al.Five-year biochemical outcome following permanent interstitial brachythreapy for clinical T1-T3 prostate cancer.Int J Radiat Oncol Biol Phys,2001,51:41-48.
  • 7Kono Y,Kubota K,Mitsumoto T,et al.Scintigraphic detection of 125I seeds after permanent brachytherapy for prostate cancer.J Nucl Med,2008,49:541-545.
  • 8Potters L,Morgenstern C,Calugaru E,et al.12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer.J Urol,2008,179:S20-24.
  • 9Damico A.Radiation and hormonal therapy for locally advanced and clinically localized prostate cancer.Urology,2001,58:78-82.
  • 10Crook JM,Sznmacher E.Intermittent androgen suppression in the management of prostate cancer.Urology,1999,56:530-534.

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部